Evidence map›Paper›PMID 17428853›Full record

ArticleJournal of virology2007

Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells.

Meghann Teague Getts, Byung S Kim, Stephen D Miller

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Cytotoxic CD8Brain pathology (Zurich, Switzerland) · 2018
    Article
  6. Exploiting apoptosis for therapeutic tolerance induction.Journal of immunology (Baltimore, Md. : 1950) · 2013
    Review
  7. Review
  8. Targeting the B7 family of co-stimulatory molecules: successes and challenges.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2013
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Meghann Teague GettsDepartment of Microbiology and Immunology and Interdepartmental Immunobiology Center, Northwestern University Feinberg School of Medicine, 303 E. Chicago Avenue, Chicago, IL 60611, USA.
Byung S Kim
Stephen D Miller
Northwestern University · US

Funding

T-CELL IMMUNITY IN TMEV-INDUCED DEMYELINATIONP01NS023349 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LIPTON, HOWARD LEE · 1986 to 2007
$8.9M
Antigen-specific T cell tolerance and CNS autoimmunityF31AI060338 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TEAGUE, MEGHANN · 2004 to 2006
$85k
NIAID NIH HHS F31 AI-060338NIAID NIH HHS F31 AI060338NINDS NIH HHS NS-023349NINDS NIH HHS P01 NS023349
6 · The paper itself

Abstract

Tolerance induced by the intravenous injection of peptide-pulsed, ethylene carbodiimide (ECDI)-fixed splenic antigen-presenting cells (Ag-SP) is a safe and effective method of inducing specific unresponsiveness in CD4+ T cells for the prevention and treatment of a variety of autoimmune diseases. We determined whether Ag-SP tolerance could also be used to tolerize CD8+ T cells. We show in the Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease model of multiple sclerosis that CD8+ T cells specific for both dominant and subdominant epitopes can be rendered tolerant. Interestingly, although virus clearance was delayed, lack of the virus-specific cytotoxic T-lymphocyte response did not result in the conversion of normally TMEV-resistant C57BL/6 mice to a susceptible phenotype. Importantly, we found that Ag-SP tolerance may not be a practical treatment for human diseases in which CD8+ T cells play a major role in pathogenesis, as tolerance induction in mice previously infected with TMEV led to a severe, often fatal reaction.

Indexed as

Immune ToleranceAnimalsAntigen-Presenting CellsAutoimmune DiseasesCarbodiimidesCD8-Positive T-LymphocytesCentral Nervous SystemCytokinesEpitopesFlow CytometryHumansMiceMice, Inbred C57BLSpleenTheilovirusCarbodiimidesCytokinesEpitopes

Identifiers

PMID17428853
PMCPMC1900084
OpenAlexW2152459019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.